Skip to content

Tumour Registry Colorectal Cancer

Prospective and Retrospective Observation of the Adjuvant and Palliative Treatment Strategies in the Therapy of Colorectal Cancer in Germany

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00910819
Acronym
TKK
Enrollment
7000
Registered
2009-06-01
Start date
2006-09-30
Completion date
2022-03-31
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer, Advanced Colorectal Cancer, Epidemiology, Health Services Research, Germany, Registry, Palliative Care, Palliative Treatment, Adjuvant Drug Therapy, Nutrition Assessment, Physical Activity

Brief summary

To describe treatment reality of patients with colorectal cancer treated by office-based and clinic-based medical oncologists in Germany.

Detailed description

The TKK is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of colorectal cancer in Germany. The registry will follow patients for up to five years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. The impact of nutrition (CoNut) and physical activity (CoNut) on the course of the adjuvant disease will be examined, as well as long-term effects of adjuvant treatment (CoTox) and the final phase of the palliative process (CoLife). Based on the available data a prognostic score will be developed.

Interventions

None listed

Sponsors

Arbeitskreis Klinische Studien
CollaboratorOTHER
Arbeitsgemeinschaft fur Internistische Onkologie
CollaboratorOTHER
iOMEDICO AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Colorectal cancer * 18 years and older * Antineoplastic treatment

Exclusion criteria

* No colorectal cancer * Below 18 years * No antineoplastic treatment

Design outcomes

Primary

MeasureTime frame
Course of Antineoplastic Treatment5 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026